Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Hope for a rare disease: eculizumab in neuromyelitis optica.
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
Identifying the Start of Multiple Sclerosis Injury: A Serial DTI Study.
Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.
Comparative validity of accelerometer based measures of physical activity for people with multiple sclerosis.
Multiple sclerosis: Phases of disease improvement unrelated to relapses.
The underdiagnosis of sleep disorders in patients with multiple sclerosis.
Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis.
B-89Comparison of Driving Performance, Cognition, and Physical Symptoms in Individuals with Multiple Sclerosis and Healthy Controls.
Relapsing-Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells.
HERVs in neuropathogenesis.
Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.
Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography.
Segmentation of Multiple Sclerosis Lesions in Brain MR Images Using Spatially Constrained Possibilistic Fuzzy C-Means Classification.
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.
Myelination of rodent hippocampal neurons in culture.
Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis.
Labor induction and augmentation in women with multiple sclerosis.
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.
MRI criteria distinguishing seropositive NMO spectrum disorder from MS.
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.
Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Effect of fingolimod (FTY720) on cerebral blood flow, platelet function, and macular thickness in healthy volunteers.
Pages
« first
‹ previous
…
246
247
248
249
250
251
252
253
254
…
next ›
last »